Ikeda-Iwabu, Y.; Taniyama, Y.; Katsuragi, N.; Sanada, F.; Koibuchi, N.; Shibata, K.; Shimazu, K.; Rakugi, H.; Morishita, R.
Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis. Cells 2021, 10, 892.
https://doi.org/10.3390/cells10040892
AMA Style
Ikeda-Iwabu Y, Taniyama Y, Katsuragi N, Sanada F, Koibuchi N, Shibata K, Shimazu K, Rakugi H, Morishita R.
Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis. Cells. 2021; 10(4):892.
https://doi.org/10.3390/cells10040892
Chicago/Turabian Style
Ikeda-Iwabu, Yuka, Yoshiaki Taniyama, Naruto Katsuragi, Fumihiro Sanada, Nobutaka Koibuchi, Kana Shibata, Kenzo Shimazu, Hiromi Rakugi, and Ryuichi Morishita.
2021. "Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis" Cells 10, no. 4: 892.
https://doi.org/10.3390/cells10040892
APA Style
Ikeda-Iwabu, Y., Taniyama, Y., Katsuragi, N., Sanada, F., Koibuchi, N., Shibata, K., Shimazu, K., Rakugi, H., & Morishita, R.
(2021). Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis. Cells, 10(4), 892.
https://doi.org/10.3390/cells10040892